The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication

被引:213
作者
Rask-Andersen, Mathias [1 ,2 ]
Masuram, Surendar [1 ,2 ,3 ]
Schioth, Helgi B. [1 ,2 ]
机构
[1] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden
[2] Uppsala Univ, Uppsala Biomed Ctr, S-75124 Uppsala, Sweden
[3] Uppsala Monitoring Ctr, S-75140 Uppsala, Sweden
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 | 2014年 / 54卷
关键词
drug targets; clinical trials; kinase; cancer; diabetes; inflammation; DISCOVERY; OPINION; CANCER;
D O I
10.1146/annurev-pharmtox-011613-135943
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The largest innovations within pharmaceutical development come through new compounds that have unique and novel modes of action. These innovations commonly involve expanding the protein space targeted by pharmaceutical agents. At present, information about drugs and drug targets is available online via public databases such as DrugBank and the Therapeutic Targets Database. However, this information is biased, understandably so, toward established drugs and drug-target interactions. To gain a better overview of the drug-targeted portion of the human proteome and the directions of current drug development, we developed a data set of clinical trial drug-target interactions based on CenterWatch's Drugs in Clinical Trials Database, one of the largest databases of its kind. Our curation identified 475 potentially novel clinical trial drug targets. This review aims to identify trends in drug development based on the potentially novel targets currently being explored in clinical trials.
引用
收藏
页码:9 / 26
页数:18
相关论文
共 34 条
[31]   Lorcaserin, a novel selective human 5-Hydroxytryptamine2C agonist:: In vitro and in vivo pharmacological characterization [J].
Thomsen, William J. ;
Grottick, Andrew J. ;
Menzaghi, Frederique ;
Reyes-Saldana, Hazel ;
Espitia, Stephen ;
Yuskin, Diane ;
Whelan, Kevin ;
Martin, Michael ;
Morgan, Michael ;
Chen, Weichao ;
Al-Shamma, Hussien ;
Smith, Brian ;
Chalmers, Derek ;
Behan, Dominic .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (02) :577-587
[32]  
Webb EC, 1992, ENZYME NOMENCLATURE
[33]   DrugBank:: a comprehensive resource for in silico drug discovery and exploration [J].
Wishart, David S. ;
Knox, Craig ;
Guo, An Chi ;
Shrivastava, Savita ;
Hassanali, Murtaza ;
Stothard, Paul ;
Chang, Zhan ;
Woolsey, Jennifer .
NUCLEIC ACIDS RESEARCH, 2006, 34 :D668-D672
[34]   Targeting cancer with small molecule kinase inhibitors [J].
Zhang, Jianming ;
Yang, Priscilla L. ;
Gray, Nathanael S. .
NATURE REVIEWS CANCER, 2009, 9 (01) :28-39